In conclusion, ACAN, FREM1, TOP2A and UCHL1 were established as diagnostic markers and potential immunotherapeutic targets for MMD by single cell, WGCNA, differential expression analysis and three machine learning methods. The gene discussed is TOP2A; the disease is multiminicore myopathy.